Elevated serum level of thioredoxin in patients with hepatocellular carcinoma

Biotherapy

Volumn 11, Issue 4, 1998, Pages 277-288

  Miyazaki, Kunihisa ^a,b,c,d   Noda, Noriko ^a,b   Okada, Shuichi ^a   Hagiwara, Yoshiaki ^a   Miyata, Michio ^a   Sakurabayashi, Ikunosuke ^a   Yamaguchi, Naohito ^a   Sugimura, Takashi ^a   Terada, Masaaki ^a,b   Wakasugi, Hiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d Immuno Biological Laboratories Co Ltd   (Japan)

Author keywords

Autocrine growth factor; ELISA; Malignant diseases; Redox enzyme

Indexed keywords

THIOREDOXIN;

ARTICLE; BLOOD SAMPLING; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; ALPHA-FETOPROTEINS; ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MICE; MIDDLE AGED; REFERENCE VALUES; THIOREDOXIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0032412002     PISSN: 0921299X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008032703468     Document Type: Article

References (45)

1. Luthman M, Holmgren A. Rat liver thioredoxin and thioredoxin reductase: purification and characterization. Biochem 1982; 21(26): 6628-33.
2. Laurent TC, Moore EC, Reichard P. Enzymic synthesis of deoxyribonucleotides. J Biol Chem 1964; 239; 3436-44.
3. Murk DK Richardson CC. Escherichia coli Ihioredoxin: a subunil of bacleriophagc T7 DNA polymerase. Proc NatI Acad Sei USA 1976; 73(3): 780-4.
4. Wakasugi H, Rimsky L. Mane Y, Kamel AM. Fradclixi D, Tursz T. Bertoglio J. Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor. Proc NatI Acad Sei USA 1987: 84(3): 804-8.
5. Yodoi J. Takatsuki K. Masuda T. Letter: Two cases of T-ccll chronic lymphocytic leukemia in Japan. N EngI J Med 1974; 290(10): 572-3.
6. Teshigawara K, Maeda M, Nishino K. Nikaido T. Uchiyama T. Tsudo M. Wano Y, Yodoi J. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression. J Mol Cell Immunol 1985:2(1): 17-26.
7. Wakasugi N, Tagaya Y. Wakasugi H, Mitsui A. Maeda M, Yodoi J.Tursz T. Adult T-ccll leukemia-derived factor/lhiorcdoxin, produced by both human T-lymphotropic \irus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with inlerIcukin 1 and interleukin 2. Proc NatI Acad Sei USA 1990: 87(21): 8282-6.
8. Balcewicx-Sablinska MK. Wollman EE. Gorti R.Silberstein DS. Human eosinophil cytotoxicity-cnhancing factor. II. Multiple forms symhesi/ed by U937 cells and their relationship to thioredoxin/adult T cell leukemia-derived factor. J Immunol 1991: 147(7): 2I7(M.
9. Tonissen KF. Wells JR. Isolation and characterization of human thiorcdoxin-encoding genes. Gene 1991: 102(2): 221-8.
10. Holmgren A, Thioredoxin catalyzes the reduction of insulin disuln'des by dithiothieitol and dihydrolipoamide. J Biol Chem 1979; 254(19): 9627-32.
11. Cirippo JF. Holmgren A. Pratt WB. Proof that the endogenous, heat-stable glucocorticoid receptor-activating factor is thioredoxin. J Biol Chem 1985: 260( 1 ): 93-7.
12. Matthews JR. Wakasugi N. Virclizier JL. Yodoi J. Hay RT. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res 1992: 20( 15): 3821-30.
13. Pigiel VP, Schuster BJ. Thioredoxin-catalyzed refolding of disulh'de-containing proteins. Proc Nail Acad Sei USA 1986: 83(20): 7643-7.
14. Biguel C. Wakasugi N. Mishal Z. Holmgren A. Chouaib S. Turs/ T. Wakasugi H. Thioredoxin increases the proliferation of human B-cell lines through a protein kinase C-dependent mechanism. J Biol Chem 1994: 269(46): 28865-70.
15. Schallreuter KU, Wood JM. The role of Ihioredoxin reductase in the reduction of free radicals at the surface of the epidermis. Biochem Biophys Res Commun 1986: 136(2): 630-7.
16. Spector A. Yan GZ. Huang RR. McDermott MJ. Gascoyne PR. Pigict V. The effect of H2O2 upon thioredoxin-enriched lens epithelial cells. J Biol Chem 1988: 263(10): 4984-90.
17. Matsuda M. Masutani H. Nakamura H. Miyajima S. Yamauchi A. Yonehara S. Uchida A. Irimajiri K, Horiuchi A. Yodoi J. Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J Immunol 1991: 147(11 ): 3837-41.
18. Hill HZ. Cathcart KM. Bargellini J. Trizna Z, Hill GJ. Schallreuter KU. Wood JM. Does melanin affect the low LET radiation response of Cloudman S91 mouse melanoma cell lines? Pigment Cell Res 1991; 4(2): 80-6.
19. Lunn CA. Pigict VP. The effect of thioredoxin on the radiosensitivity of bacteria. Int J Radial Biol Relat Stud Phys Chem Med 1987:51(1): 29-38.
20. Suchi Y. Hirota K, Masutani H. Toda K, Okamoto T. Takigawa M Yodoi J. Induction of ADF/TRX by oxidative stress in keratinocytes and lymphoid cells. Iinmunol Lett 1995: 44(2-3): 189-93.
21. Durst M. Gissmann L. Ikenberg H. zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Nail Acad Sei USA 1983: 80(12): 3812-5.
22. Schwarz E. Freese UK, Gissmann L. Mayer W, Roggenhuck B. Stremlau A. zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985:314(6006): 111-4.
23. Tsunokawa Y, Takebe N. Kasamatsu T. Terada M. Sugimura T. Transforming activity of human papillomavirus type 16 DNA sequence in a cervical cancer. Proc Nail Acad Sei USA 1986: 83(7): 2200-3.
24. Fujii S. Nanbu Y. Nonogaki H. Konishi I. Mori T. Masutani H. Yodoi J. Coexpression of adult T-cell leukemia-derived factor, a human thioredoxin homologue, and human papillomavirus DNA in neoplastic cervical squamous epithelium. Cancer 1991: 68(7): 1583-91.
25. Nakamura H. Masutani H. Tagaya Y. Yamauchi A, Inamoto T. Nanbu Y. F'ujii S. Ozawa K. Yodoi J. Expression and growthpromoting effect of adult T-cell leukemia-derived factor. A human thioredoxin homologue in hepatocellular carcinoma. Cancer 1992:69(8): 2091-7.
26. Kawahara N. Tanaka T. Yokomizo A. Nanni H. Ono M. Wada M. Kohno K, Takenaka K. Sugimachi K. Kuwano M. Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin. Cancer Res. 1996; 56: 5330-3.
27. Blomback B. Blombäck M. Finkheiner W. Holmgren A. Kowalska-Loth B. Olovson G. Enzymatic reduction of disulfide bonds in librin-ogen by the thioredoxin system I. Identification of reduced bonds and studies on reoxidation process. Thrombosis Research 1974: 4: 55-75.
28. Holmgren A. Euthman M. Tissue distribution and subcellular localization of bo\ine thioredoxin determined by radiohnmunoassay. Biochem 1978: 17( 19): 4071-7.
29. Mitsui A. Hirakawa T. Yodoi J. Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin. Biochem Biophys Res Commun 1992: 186(3): 1220-6.
30. Tagaya Y. Maeda Y. Mitsui A. Kondo N. Matsui H. Hamuro J. Broun N. Arai K. Yokota T. Wakasugi H. Yodoi J. ATE derived factor (ADF), an IE-2 receptor/Tac inducer homologous to thioredoxin: possible involvement of dithiol-reduction in the IE-2 receptor induction [published erratum appears in EMBO J 1994 May 1: 13(9): 2244]. Embo J 1989: 8(3): 757-64.
31. Holmgren A. Enzymatic reduction-oxidation of protein disulfides by thioredoxin. Methods En/ymol 1984: 107: 295-300.
32. Schallreuter KU. Wood JM. Azelaic acid as a competitive inhibitor of thioredoxin reductase in human melanoma cells. Cancer Eett 1987: 36(3): 297-305.
33. Kitaoka Y. Sorachi K, Nakamura H. Masutani H, Mitsui A. Kobayashi F. Mon T. Yodoi J. Detection of adult T-ecll leukemia-derived factor/human thioredoxin in human scrum. Immunol Eett 1994:41(2-3): 155-61.
34. Aurameas S. Ternynck T. Enzyme linked immunosorbcnt assay. In: Roitt IM. Delves PJ. eds. Encyclopedia of immunology. Academic press. 1992: 508-10. vol 1 ).
35. Norusis MJ. Manual of SPSS base system v6.1. SPSS Inc. 1993.
36. Scheffe H. The analysis of variance. John Wiley and Sons, 1959.
37. Norusis MJ. Manual of SPSS Advanced Statistics v6.1. SPSS Inc. 1994.
38. Dunn OJ, Clark VA. Applied Statistics: Analysis of variance and regression. John Wiley and Sons, 1974.
39. Nakamura H, De Rosa S, Roederer M, Anderson MT, Dubs JG, Yodoi J, Holmgren A, et al. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int. Immunol. 1996; 8:603-11.
40. Parkin DM, Stjernsward J, Muir CS. Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ 1984; 62(2): 163-82.
41. Tanaka K, Hirohata T, Koga S, Sugimachi K, Kanematsu T, Ohryohji F, Nawata H, Ishibashi H, Maeda Y, Kiyokawa H, Tokunaga K, Irita Y, Takeshita S, Arase Y, Nishino N. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991; 51 (11): 2842-7.
42. Kuromatsu R, Tanaka M, Tanikawa K. Serum alfa-fetoprotein and lens culinaris aggulutinin-reactive fraction of alphafetoprotein in patients with hepatocellular carcinoma. Liver 1993; 13: 177-82.
43. Lee HB, Yoo OJ, Ham JS, Lee MH. Serum alpha 1-antitrypsin in patients with hepatocellular carcinoma. Clinica Chimica Acta 1992; 206: 225-30.
44. Oka H, Kurioka N, Kim K, Kanno T, Kuroki T, Mizoguchi Y, Kobayashi K. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990; 12(4 Pt 1): 680-7.
45. Raedle J, Roth WK, Oremek G, Caspary WF, Zeuzem S. Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C. Digestive Diseases & Sciences 1995; 40: 2587-94.